Related Experiment Video

Updated: May 14, 2026

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
08:41

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Published on: October 27, 2014

The pharmacological bases of the antiangiogenic activity of paclitaxel

Guido Bocci1, Antonello Di Paolo, Romano Danesi

  • 1Division of Pharmacology, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 55, 56126 Pisa, Italy.

Angiogenesis
|February 8, 2013
PubMed

Insights

Paclitaxel exhibits antiangiogenic properties by inhibiting endothelial cell function and regulating key molecular signals. Novel formulations enhance its effectiveness, offering new strategies for cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Paclitaxel's antineoplastic effects are partly attributed to its antiangiogenic activity.
  • Research since the mid-1990s has explored this mechanism.
  • Angiogenesis is crucial for tumor growth and metastasis.

Purpose of the Study:

  • To review the antiangiogenic mechanisms of paclitaxel.
  • To evaluate the impact of novel paclitaxel formulations on antiangiogenic activity.
  • To discuss therapeutic strategies based on paclitaxel's antiangiogenic potential.

Main Methods:

  • Review of preclinical studies on paclitaxel's antiangiogenic effects.
  • Analysis of molecular mechanisms including tubule formation, cell migration, and proliferation.
  • Investigation of effects on vascular endothelial growth factor (VEGF), Angiopoietin-1 (Ang-1), and Thrombospondin-1 (TSP-1).

Main Results:

  • Paclitaxel inhibits endothelial cell tubule formation and migration.
  • It exhibits antiproliferative effects on activated endothelial cells.
  • Paclitaxel downregulates tumor cell expression of VEGF and Ang-1, and increases TSP-1 secretion.

Conclusions:

  • Paclitaxel possesses significant antiangiogenic activity through multiple mechanisms.
  • Novel drug delivery systems enhance its in vivo antiangiogenic efficacy.
  • Preclinical findings support developing paclitaxel-based therapies to control tumor progression.

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...